See Dr. Ebrahim and learn about THE RETINA INSTITUTE on Channel 4 WWL TV on Saturdays at 10:30am.
THE RETINA INSTITUTE
tracks the latest
retinal eye research
and now you can too:
CLICK TO ACCESS YOUR PATIENT PORTAL
While your relationship with your doctor can seem lost in an increasingly corporate medical environment, highly personalized medicine by Dr. Ebrahim is our first priority. At THE RETINA INSTITUTE you will see Dr. Ebrahim himself, at a central location with superior technology, such that you benefit from world class retinal eye care in a personal and professional setting.
HEALTH PLANS ACCEPTED BY THE RETINA INSTITUTE
RETINAL EYE CARE UPDATES:
Derived from sharks, squalamine drops are under clinical study and may prove beneficial in the treatment of macular degeneration.
Our high density macular microperimetry and highly sensitive electroretinography technologies are capable of detecting subclinical retinal decline before major vision loss to allow prevention.
Our low duty cycle yellow micropulse laser technology allows the benefits of early treatment in a manner safer than traditional laser.
Targeted genetic therapy shows promising preliminary human trials in reversing choroideremia, a macular degeneration type disorder.
PDGFR-beta antibody (an inhibitor of Platelet Derived Growth Factor beta) has long been on the radar as a potential treatment for wet macular degeneration. Now the maker of Eylea has teamed with Bayer in an attempt to bring an Eylea/PDGFR-beta combination to market. Stay tuned for updates. If successful, the benefit may extend beyond macular degeneration to diabetics and vein occlusion patients as well as others.
Derived from early stem cell research, new treatments may introduce regenerative factors to rejuvenate currently ailing retinal cells without requiring true stem cell transplantation.
There is good reason to be patient for the perfection of true stem cell applications (click here to proceed to the link).
The first retinal prosthesis to gain FDA approval is the ARGUS II Retinal Prosthesis System. Though currently it has limited uses, it brings great hope to those with severe retinal disease.
Eylea (aflibercept) has now been approved for use in diabetics. It has been very successful for macular degeneration and retinal vein occlusions.
Concerned about your genetic risk for macular degeneration? Testing is available at THE RETINA INSTITUTE.
For diabetics, regular follow up and treatment by retinal eye doctors are proven to save vision. Conversely, lack of examination can lead to unnecessary vision loss.
High blood pressure (Hypertension) can cause serious vision loss: baseline blood pressure as well as spiking blood pressures from stress or sleep apnea can contribute to vision loss.
Floaters and flashes can signal retinal detachments.
Blurry vision can be much more than a need for glasses. A retinal exam can rule out or treat true eye disease.
FOLLOW OUR EVENTS
UNDERSTAND RETINAL EYE DISEASE FROM DIABETES
Click to test your knowledge of
diabetic eye disease.
UNDERSTAND MACULAR DEGENERATION
UNDERSTAND RETINAL EYE DISEASE FROM HIGH BLOOD PRESSURE
THE RETINA INSTITUTE accepts referrals by appointment from Doctors both local and distant.
UNDERSTAND RETINAL DETACHMENTS
Are you in need of a primary care physician to address your chronic or urgent medical needs? Visit our neighbor LA PRIMARY CARE at www.LAPCNOLA.com.
LEAVE US YOUR FEEDBACK